Not Yet RecruitingNot Applicable

Personalized Closed-Loop Brain Stimulation for Patients With Primary Progressive Aphasia

United States10 participantsStarted 2026-06

Plain-language summary

This research study investigates the feasibility and efficacy of a personalized, closed-loop electroencephalogram-transcranial electrical stimulation (EEG-tES) intervention for individuals with Primary Progressive Aphasia (PPA), addressing the inconsistent results of generic brain stimulation protocols. By integrating artificial intelligence (AI)-derived insights with real-time data, the study aims to customize transcranial electrical stimulation (tES) parameters, including electrode placement, intensity, and frequency to target the specific brain regions responsible for abnormal signaling in each participant. Over the intervention period paired with computerized cognitive training, the project will evaluate improvements in learning, memory, and functional connectivity, while simultaneously identifying clinical and physiological predictors to determine the viability of transitioning this low-cost, non-invasive technology into a remotely supervised, home-based therapy setting. The study duration will be a total of 6-8 weeks.

Who can participate

Age range45 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Must be between 45-85 years of age. * Must be right-handed. * Must be proficient in English. * Must have a minimum of high-school education. * Must be diagnosed as lvPPA with AD biomarkers. Other possible diagnosis for the 'aphasic AD' variant would be MCI or 'possible AD' according to 2011 guidelines with AD biomarkers (CSF or positron emission tomography (PET) amyloid-beta or fluorodeoxyglucose (FDG)-positron emission tomography (PET) with uni-hemispheric atrophy). * Participants will be diagnosed from PPA and early dementias clinics at Johns Hopkins University or other specialized centers in US using current consensus criteria. Diagnosis will be based on neuropsychological testing, language testing (most commonly the Western Aphasia Battery), MRI and clinical assessment. The investigators will also use two new variant classification tests the investigators have developed at the lab which discriminate PPA variants with great accuracy (above 80%): a spelling test and a speech production test (i.e., Cookie Theft picture description task). Exclusion Criteria: * People with previous neurological disease including vascular dementia (e.g., stroke, developmental dyslexia, dysgraphia or attentional deficit). * People with hearing loss (\> 25 decibel, using audiometric hearing screen). * People with uncorrected visual acuity loss. * People with advanced dementia or severe language impairments (MMSE \<15, or Montreal Cognitive Assessment \<10, or language Fro…

What they're measuring

Change in auditory recall accuracy based on the sum of words recalled in Trials 1-5 of semantically related - trained word-lists

Timeframe: Before intervention, immediately after intervention and 1 month post intervention

Change in auditory delayed recall accuracy of semantically related - trained word-lists

Timeframe: Before intervention, immediately after intervention and 1 month post intervention

Change in auditory recall accuracy based on the sum of words recalled in Trials 1-5 of semantically unrelated - trained word-lists

Timeframe: Before intervention, immediately after intervention and 1 month post intervention

Change in auditory delayed recall accuracy of semantically unrelated - trained word-lists

Timeframe: Before intervention, immediately after intervention and 1 month post intervention

Change in auditory recall accuracy based the sum of words recalled in Trials 1-5 of semantically related - untrained word-lists

Timeframe: Before intervention, immediately after intervention and 1 month post intervention

Change in auditory delayed recall accuracy of semantically related - untrained word-lists

Timeframe: Before intervention, immediately after intervention and 1 month post intervention

Trial details

NCT IDNCT07511179

SponsorJohns Hopkins University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-08

View on ClinicalTrials.gov More PPA trials